Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
Blood · 23.02.2023 · 141 (8) · 917-929
DOI: 10.1182/blood.2022016846 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood, erschienen am 23.02.2023. Verfasst von Christian Pecquet und 41 weiteren Autor:innen. Beteiligte Einrichtung: Ludwig Cancer Research, Brussels, Belgium. Hauptthemen laut MEDLINE: Myeloproliferative Disorders, Neoplasms. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Austrian Science Fund FWF.
Abstract (Originalsprache)
Mutant calreticulin (CALR) proteins resulting from a −1/+2 frameshifting mutation of the CALR exon 9 carry a novel C-terminal amino acid sequence and drive the development of myeloproliferative neoplasms (MPNs). Mutant CALRs were shown to interact with and activate the thrombopoietin receptor (TpoR/MPL) in the same cell. We report that mutant CALR proteins are secreted and can be found in patient plasma at levels up to 160 ng/mL, with a mean of 25.64 ng/mL. Plasma mutant CALR is found in complex with soluble transferrin receptor 1 (sTFR1) that acts as a carrier protein and increases mutant CALR half-life. Recombinant mutant CALR proteins bound and activated the TpoR in cell lines and primary megakaryocytic progenitors from patients with mutated CALR in which they drive thrombopoietin-independent colony formation. Importantly, the CALR-sTFR1 complex remains functional for TpoR activation. By bioluminescence resonance energy transfer assay, we show that mutant CALR proteins produced in 1 cell can specifically interact in trans with the TpoR on a target cell. In comparison with cells that only carry TpoR, cells that carry both TpoR and mutant CALR are hypersensitive to exogenous mutant CALR proteins and respond to levels of mutant CALR proteins similar to those in patient plasma. This is consistent with CALR-mutated cells that expose TpoR carrying immature N-linked sugars at the cell surface. Thus, secreted mutant CALR proteins will act more specifically on the MPN clone. In conclusion, a chaperone, CALR, can turn into a rogue cytokine through somatic mutation of its encoding gene.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Ludwig Cancer Research, Brussels, Belgium.
- Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.
- Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
- INSERM, Unité Mixte de Recherche (UMR) 1287, Gustave Roussy, Villejuif, France.
- Université Paris Cité, UMR 1287, Gustave Roussy, Villejuif, France.
- UMR 1287, Gustave Roussy, Villejuif, France.
ORCID-Profile: Christian Pecquet, Nicolas Papadopoulos, Thomas Balligand, Ilyas Chachoua, Didier Vertommen, Anita Roy, Caroline Marty, Tudor E Fertig, Daciana S Marta, Ilaria Casetti, Elisa Rumi, Daniela Pietra, Mario Cazzola, Norio Komatsu, Marito Araki, Roman Lesyk, Veronika Buxhofer-Ausch, Sonja Heibl, Isabelle Plo, William Vainchenker, Robert Kralovics, Stefan N Constantinescu
Förderung
- Austrian Science Fund FWF
Zitieren
APA
Pecquet, C., Papadopoulos, N., Balligand, T., Chachoua, I., Tisserand, A., Vertenoeil, G., Nédélec, A., Vertommen, D., Roy, A., Marty, C., Nivarthi, H., Defour, J. P., El-Khoury, M., Hug, E., Majoros, A., Xu, E., Zagrijtschuk, O., Fertig, T. E., Marta, D. S., …, & Constantinescu, S. N. (2023). Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms. Blood, 141(8), 917-929. https://doi.org/10.1182/blood.2022016846
Vancouver
Pecquet C, Papadopoulos N, Balligand T, Chachoua I, Tisserand A, Vertenoeil G, et al. Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms. Blood. 2023;141(8):917-929. doi:10.1182/blood.2022016846
BibTeX
@article{Pecquet2023,
author = {Pecquet, Christian and Papadopoulos, Nicolas and Balligand, Thomas and Chachoua, Ilyas and Tisserand, Amandine and Vertenoeil, Gaëlle and Nédélec, Audrey and Vertommen, Didier and Roy, Anita and Marty, Caroline and Nivarthi, Harini and Defour, Jean-Philippe and El-Khoury, Mira and Hug, Eva and Majoros, Andrea and Xu, Erica and Zagrijtschuk, Oleh and Fertig, Tudor E and Marta, Daciana S and Gisslinger, Heinz and Gisslinger, Bettina and Schalling, Martin and Casetti, Ilaria and Rumi, Elisa and Pietra, Daniela and Cavalloni, Chiara and Arcaini, Luca and Cazzola, Mario and Komatsu, Norio and Kihara, Yoshihiko and Sunami, Yoshitaka and Edahiro, Yoko and Araki, Marito and Lesyk, Roman and Buxhofer-Ausch, Veronika and Heibl, Sonja and Pasquier, Florence and Havelange, Violaine and Plo, Isabelle and Vainchenker, William and Kralovics, Robert and Constantinescu, Stefan N},
title = {Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms},
journal = {Blood},
year = {2023},
volume = {141},
number = {8},
pages = {917--929},
doi = {10.1182/blood.2022016846}
}
EUVIMED